|By Marketwired .||
|June 9, 2014 09:42 AM EDT||
ST. LOUIS, MO -- (Marketwired) -- 06/09/14 -- SNMMI 2014, Booth 400 - Today at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, TriFoil Imaging announced the launch of a new tabletop series of systems for in-vivo molecular imaging. The first table top system to include full 360O CT, the InSyTe series will include multiple configurations including PET, SPECT and optical modalities.
According to Kevin Parnham, CEO of TriFoil Imaging, "The new InSyTe system with multiple configuration options, offers researchers new flexibility in choosing a mode or combination of modes in a more compact, lower cost device. It incorporates TriFoil's top-quality technologies across PET, SPECT, optical and CT for mice and small rats."
TriFoil Imaging develops devices used by medical researchers for their advanced live-subject imaging needs across a wide range of applications. InSyTe's unique system offers the highest quality at the best value by offering PET, SPECT, optical and CT modalities in a compact, easy to use package. The system can be purchased with a single modality at the start and upgraded later to incorporate CT. It has a simple, consistent user-friendly interface for image reconstruction and co-registration across all modalities.
The addition of the InSyTe expands TriFoil Imaging's product offering, which currently includes the Triumph II, a tri-modality (PET/SPECT/CT) imaging system, the eXplore CT 120 In vivo Micro CT scanner, and now, InSyTe, the first table top multi-mode imaging system with in-line CT.
"Larger systems of the past have caused a space shortage in both large and small facilities. In creating a smaller system, we aim to give labs the ability to expand technology without having to build an area to house it," explains Parnham. "The INSYTE series provides laboratories the ability to purchase an imaging system that is not only lower in price but capable of producing high-contrast, clinical-grade images, maximizing throughput while minimizing cost."
About TriFoil Imaging
Leading research laboratories around the world depend on TriFoil Imaging (formerly Gamma Medica - Ideas Pre-Clinical) technology to meet all their advanced in-vivo molecular imaging needs. TriumphTM is the world's first tri-modality system (including PET, SPECT, and CT) to offer the highest quality and the best value by combining three modalities all in one reliable and easy-to-use system. Founded in 2001 and now owned by Capital Resource Partners, TriFoil is headquartered in Chatsworth, California. Please visit www.trifoilimaging.com to learn more.
BluePoint Venture Marketing for TriFoil Imaging